Development of diabetes mellitus following hormone therapy in prostate cancer patients is associated with early progression to castration resistance
Abstract To identify risk factors for the prognosis of prostate cancer (PC), we retrospectively analyzed the impact of lifestyle-related disorders as well as PC characteristics at initial diagnosis on the progression to castration-resistant PC (CRPC) in PC patients undergoing hormone therapy. Of 648...
Guardado en:
Autores principales: | Tomonori Hayashi, Tomoyoshi Miyamoto, Noriaki Nagai, Atsufumi Kawabata |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9be7617cad6749498196df2c4e85778a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Castration-resistant prostate cancer: potential targets and therapies
por: Parray A, et al.
Publicado: (2012) -
KIF15 Promotes Progression of Castration Resistant Prostate Cancer by Activating EGFR Signaling Pathway
por: Lin Gao, et al.
Publicado: (2021) -
Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Shangwei Zhong, et al.
Publicado: (2021) -
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021) -
Utility of prophylactic antibiotics for preventing febrile neutropenia during cabazitaxel therapy for castration-resistant prostate cancer
por: Keitaro Watanabe, et al.
Publicado: (2021)